{
    "id": 23696,
    "fullName": "CEP43 - FGFR1",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "CEP43-FGFR1 (also referred to as FOP-FGFR1) results from the fusion of CEP43 and FGFR1, demonstrating constitutive kinase activity, increased cell proliferation, and activation of MAPK and PI3K-AKT signaling pathways in cell culture (PMID: 11689702).",
            "references": [
                {
                    "id": 6076,
                    "pubMedId": 11689702,
                    "title": "8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/11689702"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 11116,
        "geneSymbol": "CEP43",
        "terms": [
            "CEP43",
            "FGFR1OP",
            "FOP"
        ]
    },
    "variant": "CEP43 - FGFR1",
    "createDate": "06/26/2016",
    "updateDate": "01/23/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 2260,
                "geneSymbol": "FGFR1",
                "terms": [
                    "FGFR1",
                    "bFGF-R-1",
                    "BFGFR",
                    "CD331",
                    "CEK",
                    "ECCL",
                    "FGFBR",
                    "FGFR-1",
                    "FLG",
                    "FLT-2",
                    "FLT2",
                    "HBGFR",
                    "HH2",
                    "HRTFDS",
                    "KAL2",
                    "N-SAM",
                    "OGD"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 6187,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Iclusig (ponatinib) inhibited colony growth in cells derived from a patient with 8p11 myeloproliferative syndrome harboring CEP43-FGFR1 in culture (PMID: 22875613).",
            "molecularProfile": {
                "id": 24414,
                "profileName": "CEP43 - FGFR1"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 2226,
                "name": "myeloproliferative neoplasm",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5786,
                    "pubMedId": 22875613,
                    "title": "Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22875613"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4072,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Debio 1347 inhibited proliferation of acute myeloid leukemia (AML) cells harboring CEP43 - FGFR1 in culture and reduced tumor growth in CEP43 - FGFR1-positive AML cell line xenograft models (PMID: 25169980).",
            "molecularProfile": {
                "id": 24414,
                "profileName": "CEP43 - FGFR1"
            },
            "therapy": {
                "id": 1014,
                "therapyName": "Debio 1347",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4388,
                    "pubMedId": 25169980,
                    "title": "The fibroblast growth factor receptor genetic status as a potential predictor of the sensitivity to CH5183284/Debio 1347, a novel selective FGFR inhibitor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25169980"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24414,
            "profileName": "CEP43 - FGFR1",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}